Document is current
Any future updates will be listed below
-
Authors
Ishiuchi, Naoki
Nakashima, Ayumu https://orcid.org/0000-0002-7838-1494
Maeda, Satoshi
Miura, Yoshie
Miyasako, Kisho
Sasaki, Kensuke
Uchiki, Toshio
Sasaki, Ayano
Nagamatsu, Shogo
Nakao, Naoki
Nagao, Masataka
Masaki, Takao
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22K16220)
Japan Agency for Medical Research and Development (21bk0104124h0001)
- License Information
-
More Information
Article History
Received: 1 September 2022
Accepted: 19 April 2023
First Online: 4 May 2023
Declarations
:
: Collection of the adipose tissue was approved by the Medical Ethics Committee of Hiroshima Graduate School of Biomedical Science, and written informed consent was obtained from each patient. Title of the approved project: Development of repair therapy for tissue damage using adipose-derived mesenchymal stem cells. Approval number: E-1516. Date of approval: January 29, 2019. All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Hiroshima University (Hiroshima, Japan). Title of the approved project: Mesenchymal stem cells transplantation for kidney injury and epigenetics. Approval number: A16-83. Date of approval: October 14, 2016. Title of the approved project: Suppression of renal fibrosis by mesenchymal stem cells derived from upper and lower adipose tissues. Approval number: A20-105. Date of approval: October 14, 2020.
: Not applicable.
: The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University is a collaborative research laboratory funded by TWOCELLS Company, Limited. Drs. S. Maeda and Y. Miura are researchers employed by TWOCELLS Company, Limited. Except for the abovementioned disclosures, all authors have declared that no conflict of interest exists.
